Search Articles

View query in Help articles search

Search Results (1 to 1 of 1 Results)

Download search results: CSV END BibTex RIS


Continuous Glucose Monitoring Among Patients With Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Prospective Observational Feasibility Study

Continuous Glucose Monitoring Among Patients With Type 1 Diabetes in Rwanda (CAPT1D) Phase I: Prospective Observational Feasibility Study

These alerts then allow for immediate treatment action, thereby reducing the time spent in the times outside of the euglycemic range [8]. CGMs have shown clinical significance by improving time in the euglycemic range, decreasing rates of hypoglycemia and Hb A1c levels [10], and lowering rates of emergency department visits and hospitalizations for hypoglycemia [11].

Jason Baker, Giacomo Cappon, Jean Claude Habineza, Corey H Basch, Steven Mey, Diana L Malkin-Washeim, Christian Schuetz, Niyonsenga Simon Pierre, Etienne Uwingabire, Alvera Mukamazimpaka, Paul Mbonyi, Sandhya Narayanan

JMIR Form Res 2025;9:e64585